ArticleFrontiers in immunology2025

Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma.

Liang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.